|
Aisling Capital |
|
United States |
+1 (212) 651-6380 |
Series C |
|
|
|
Boxer Capital |
|
|
|
Series C |
|
|
|
California Institute for Regenerative Medicine |
|
|
|
Grant |
|
|
|
Eric Osterdag |
Individual investor. |
|
|
Series A |
|
|
|
Longitude Capital |
|
|
|
Series C |
|
|
|
Longitude Capital |
|
|
|
Series B |
|
|
|
Malin Corp |
|
|
|
Series C |
|
|
|
Malin Corp |
|
|
|
Series B |
|
|
|
Malin Corp |
|
|
|
Series A |
|
|
|
Novartis AG |
|
|
|
Series C |
|
|
|
Pentwater Capital Management |
|
|
|
Series C |
|
|
|
Perceptive Advisors |
|
United States |
|
Series C |
|
|
|
Rapha Capital Management |
|
|
|
Series C |
|
|
|
Tavistock Life Sciences |
|
|
|
Series B |
|
|
|
Vivo Capital |
|
|
|
Series C |
|
|
|
Vivo Capital |
|
|
|
Series B |
|
|